2020
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease
Lantos PM, Rumbaugh J, Bockenstedt LK, Falck-Ytter YT, Aguero-Rosenfeld ME, Auwaerter PG, Baldwin K, Bannuru RR, Belani KK, Bowie WR, Branda JA, Clifford DB, DiMario FJ, Halperin JJ, Krause PJ, Lavergne V, Liang MH, Meissner H, Nigrovic LE, Nocton J, Osani MC, Pruitt AA, Rips J, Rosenfeld LE, Savoy ML, Sood SK, Steere AC, Strle F, Sundel R, Tsao J, Vaysbrot EE, Wormser GP, Zemel LS. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Arthritis & Rheumatology 2020, 73: 12-20. PMID: 33251716, DOI: 10.1002/art.41562.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2015
Babesiosis
Vannier EG, Diuk-Wasser MA, Mamoun C, Krause PJ. Babesiosis. Infectious Disease Clinics Of North America 2015, 29: 357-370. PMID: 25999229, PMCID: PMC4458703, DOI: 10.1016/j.idc.2015.02.008.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Bacterial AgentsBabesiaBabesiosisDNA, ProtozoanEnzyme InhibitorsErythrocytesHumansPolymerase Chain ReactionBorrelia miyamotoi infection in nature and in humans
Krause PJ, Fish D, Narasimhan S, Barbour AG. Borrelia miyamotoi infection in nature and in humans. Clinical Microbiology And Infection 2015, 21: 631-639. PMID: 25700888, PMCID: PMC4470780, DOI: 10.1016/j.cmi.2015.02.006.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsB. miyamotoi infectionMiyamotoi infectionClinical manifestationsB. miyamotoiLyme diseaseBorrelia miyamotoi infectionAcute febrile illnessCommon clinical manifestationsBlood smear examinationPublic health importanceHuman granulocytic anaplasmosisFever group spirochetesFebrile illnessAntibiotic therapyDisease groupEtiologic diagnosisSevere diseaseSmear examinationIxodes persulcatus ticksHealth importanceInfectionHuman casesGranulocytic anaplasmosisBorrelia miyamotoiDisease
2013
Lyme Disease and the Heart
Krause PJ, Bockenstedt LK. Lyme Disease and the Heart. Circulation 2013, 127: e451-e454. PMID: 23429899, DOI: 10.1161/circulationaha.112.101485.Peer-Reviewed Original Research
2011
Humans Infected with Relapsing Fever Spirochete Borrelia miyamotoi, Russia - Volume 17, Number 10—October 2011 - Emerging Infectious Diseases journal - CDC
Platonov AE, Karan LS, Kolyasnikova NM, Makhneva NA, Toporkova MG, Maleev VV, Fish D, Krause PJ. Humans Infected with Relapsing Fever Spirochete Borrelia miyamotoi, Russia - Volume 17, Number 10—October 2011 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2011, 17: 1816-1823. PMID: 22000350, PMCID: PMC3310649, DOI: 10.3201/eid1710.101474.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Bacterial AgentsAntibodies, BacterialBorreliaDoxycyclineHumansImmunoglobulin MPhylogenyRecurrenceRelapsing FeverRNA, Ribosomal, 16SRussiaConceptsB. miyamotoi infectionMiyamotoi infectionInfectious Diseases journal - CDCBorrelia miyamotoiInfluenza-like illnessB. burgdorferi infectionFever spirochete Borrelia miyamotoiDisease-like symptomsFebrile illnessI. ricinus ticksErythema migransClinical manifestationsIxodid tick vectorsBurgdorferi infectionI. scapularis ticksIxodes persulcatus ticksInfectionRicinus ticksScapularis ticksB. burgdorferiB. gariniiFeverWidespread prevalenceIllnessMiyamotoiLong-Term Lyme Disease Antibiotic Therapy Beliefs Among New England Residents
Macauda MM, Erickson P, Miller J, Mann P, Closter L, Krause PJ. Long-Term Lyme Disease Antibiotic Therapy Beliefs Among New England Residents. Vector-Borne And Zoonotic Diseases 2011, 11: 857-862. PMID: 21417921, DOI: 10.1089/vbz.2010.0116.Peer-Reviewed Original ResearchConceptsLyme diseasePersistent symptomsAntibiotic treatmentEffective doctor-patient communicationAntibiotic therapy regimensInfectious Diseases SocietyLong-term treatmentBorrelia burgdorferi infectionDoctor-patient communicationFederal health agenciesDiseases SocietyAppropriate therapyTherapy regimensAntimicrobial therapyBurgdorferi infectionHealthcare workersMost physiciansStandard diagnosisDisease controlDiseasePatientsHealth agenciesSymptomsPhysiciansMedical societies
2003
Babesiosis in Pregnancy
Feder HM, Lawlor M, Krause PJ. Babesiosis in Pregnancy. New England Journal Of Medicine 2003, 349: 195-196. PMID: 12853599, DOI: 10.1056/nejm200307103490221.Peer-Reviewed Original Research
2002
Babesiosis: similar to malaria but different.
Lantos PM, Krause PJ. Babesiosis: similar to malaria but different. Pediatric Annals 2002, 31: 192-7. PMID: 11905293, DOI: 10.3928/0090-4481-20020301-10.Peer-Reviewed Original ResearchBabesiosis
Krause PJ. Babesiosis. Medical Clinics Of North America 2002, 86: 361-373. PMID: 11982307, DOI: 10.1016/s0025-7125(03)00092-0.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsAnti-Bacterial AgentsBabesiaBabesiosisDiagnosis, DifferentialDrug Administration ScheduleHumansConceptsAge 50 yearsFlulike illnessThin blood smearsHIV infectionHospital admissionExchange transfusionAsplenic individualsImmunosuppressive drugsPolymerase chain reactionSevere casesSpecific diagnosisFatal diseaseBlood smearsProtozoal parasitesGreater riskLyme diseaseSpecific antibodiesChain reactionTransmits Lyme diseaseInfectionDiseaseBabesiosisSame tickNorthern midwestern United StatesMost cases
2001
Coinfecting Deer-Associated Zoonoses: Lyme Disease, Babesiosis, and Ehrlichiosis
Goldstein E, Thompson C, Spielman A, Krause P. Coinfecting Deer-Associated Zoonoses: Lyme Disease, Babesiosis, and Ehrlichiosis. Clinical Infectious Diseases 2001, 33: 676-685. PMID: 11486290, DOI: 10.1086/322681.Peer-Reviewed Original ResearchConceptsLyme diseaseDuration of symptomsHuman granulocytic ehrlichiosisTickborne infectionClinical managementHealth burdenHuman coinfectionsDiagnostic proceduresGranulocytic ehrlichiosisDisease syndromeHuman babesiosisRodent reservoirsHuman hostInfectionDiseaseEhrlichiosisDiversity of pathogensBabesiosisPathogensCoinfectionSyndromeSymptomsIncidenceVector hostLactobacillus acidophilus Sepsis in a Neonate
Thompson C, McCarter Y, Krause P, Herson V. Lactobacillus acidophilus Sepsis in a Neonate. Journal Of Perinatology 2001, 21: 258-260. PMID: 11533845, DOI: 10.1038/sj.jp.7200509.Peer-Reviewed Case Reports and Technical Notes
2000
Atovaquone and Azithromycin for the Treatment of Babesiosis
Krause P, Lepore T, Sikand V, Gadbaw J, Burke G, Telford S, Brassard P, Pearl D, Azlanzadeh J, Christianson D, McGrath D, Spielman A. Atovaquone and Azithromycin for the Treatment of Babesiosis. New England Journal Of Medicine 2000, 343: 1454-1458. PMID: 11078770, DOI: 10.1056/nejm200011163432004.Peer-Reviewed Original ResearchConceptsCommon adverse effectsTreatment of babesiosisAdverse reactionsAdverse effectsCourse of clindamycinRegimen of clindamycinStart of therapyMalaria-like illnessPromising alternative treatmentStandard treatmentAlternative treatmentRegimenClindamycinAzithromycinAtovaquoneMonthsDiarrheaTreatmentBabesiosisQuinineSymptomsSubjectsPercentDaysBabesia microti DNA
1998
Persistent Parasitemia after Acute Babesiosis
Krause P, Spielman A, Telford S, Sikand V, McKay K, Christianson D, Pollack R, Brassard P, Magera J, Ryan R, Persing D. Persistent Parasitemia after Acute Babesiosis. New England Journal Of Medicine 1998, 339: 160-165. PMID: 9664092, DOI: 10.1056/nejm199807163390304.Peer-Reviewed Original ResearchConceptsDuration of parasitemiaSpecific therapySide effectsInfected peopleCommunity-based studyEpisodes of illnessProtozoan Babesia microtiBabesial DNASymptoms of babesiosisRecrudescent diseaseQuinine therapyThin blood smearsPersistent parasitemiaInfected subjectsSerologic testsIll subjectsSpecific symptomsAcute babesiosisMore monthsParasitemiaBlood smearsBabesial infectionTherapyBabesia microtiSymptoms
1994
Quality Standard for Antimicrobial Prophylaxis in Surgical Procedures
Dellinger E, Gross P, Barrett T, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality Standard for Antimicrobial Prophylaxis in Surgical Procedures. Clinical Infectious Diseases 1994, 18: 422-427. PMID: 8011827, DOI: 10.1093/clinids/18.3.422.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsAnti-Bacterial AgentsHumansQuality of Health CareSocieties, MedicalSurgical Wound InfectionUnited StatesConceptsPostoperative wound infectionProphylactic antimicrobial agentsInfectious Diseases SocietyDiseases SocietyWound infectionProphylactic antibioticsReliable administrationPediatric Infectious Diseases SocietyAntimicrobial agentsInfectious diseasesQuality Standards SubcommitteeSurgical infectious diseasesSurgical Infection SocietyClinical Affairs CommitteeMethod of administrationPostoperative infectionPotential morbidityHospital epidemiologyOperative procedureInfection controlOptimal doseApparent efficacyDrug AdministrationOptimal durationHospital pharmacistsQuality Standard for Antimicrobial Prophylaxis in Surgical Procedures
Dellinger E, Gross P, Barrett T, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality Standard for Antimicrobial Prophylaxis in Surgical Procedures. Infection Control And Hospital Epidemiology 1994, 15: 182-188. DOI: 10.2307/30145558.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsAnti-Bacterial AgentsCross InfectionHospitalsHumansInfection ControlPostoperative ComplicationsPremedicationSurgical Wound InfectionConceptsPostoperative wound infectionProphylactic antimicrobial agentsInfectious Diseases SocietyDiseases SocietyWound infectionProphylactic antibioticsReliable administrationPediatric Infectious Diseases SocietyAntimicrobial agentsInfectious diseasesQuality Standards SubcommitteeSurgical infectious diseasesSurgical Infection SocietyClinical Affairs CommitteeMethod of administrationAntimicrobial prophylaxisPostoperative infectionPotential morbidityOperative procedureHospital epidemiologySurgical proceduresInfection controlOptimal doseApparent efficacyDrug AdministrationQuality Standard for the Treatment of Bacteremia
Gross P, Barrett T, Dellinger E, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality Standard for the Treatment of Bacteremia. Infection Control And Hospital Epidemiology 1994, 15: 189-192. DOI: 10.2307/30145559.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsAnti-Bacterial AgentsBacteremiaDrug UtilizationHospitalsHumansMicrobial Sensitivity TestsConceptsQuality Standards SubcommitteeInfectious Diseases SocietyTreatment of bacteremiaDiseases SocietyBlood culturesChart reviewersAdverse outcomesPediatric Infectious Diseases SocietyPlacebo-controlled trialPresence of bacteremiaSurgical Infection SocietySerious adverse outcomesAdministration of antibioticsAppropriate antimicrobial treatmentClinical Affairs CommitteeCase-control studyPositive blood culturesSpecific clinical indicationsAppropriate dosingHospitalized patientsRenal failureClinical trialsRisk factorsClinical indicationsHospital epidemiologyQuality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America.
Dellinger E, Gross P, Barrett T, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America. Infection Control And Hospital Epidemiology 1994, 15: 182-8. PMID: 8207176, DOI: 10.1086/646887.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsAnti-Bacterial AgentsCross InfectionHospitalsHumansInfection ControlPostoperative ComplicationsPremedicationSurgical Wound InfectionConceptsInfectious Diseases SocietyPostoperative wound infectionProphylactic antimicrobial agentsDiseases SocietyWound infectionProphylactic antibioticsReliable administrationPediatric Infectious Diseases SocietyAntimicrobial agentsInfectious diseasesQuality Standards SubcommitteeSurgical infectious diseasesSurgical Infection SocietyClinical Affairs CommitteeMethod of administrationAntimicrobial prophylaxisPostoperative infectionPotential morbidityHospital epidemiologyOperative procedureSurgical proceduresOptimal doseApparent efficacyDrug AdministrationOptimal durationQuality standard for the treatment of bacteremia. The Infectious Diseases Society of America.
Gross P, Barrett T, Dellinger E, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality standard for the treatment of bacteremia. The Infectious Diseases Society of America. Infection Control And Hospital Epidemiology 1994, 15: 189-92. PMID: 8207177, DOI: 10.1086/646888.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsAnti-Bacterial AgentsBacteremiaDrug UtilizationHospitalsHumansMicrobial Sensitivity TestsConceptsInfectious Diseases SocietyQuality Standards SubcommitteeTreatment of bacteremiaDiseases SocietyBlood culturesChart reviewersAdverse outcomesPediatric Infectious Diseases SocietyPlacebo-controlled trialPresence of bacteremiaSerious adverse outcomesSurgical Infection SocietyAdministration of antibioticsAppropriate antimicrobial treatmentClinical Affairs CommitteeCase-control studyPositive blood culturesSpecific clinical indicationsAppropriate dosingRenal failureHospitalized patientsProlonged hospitalizationRisk factorsClinical indicationsClinical trials
1986
Successful management of Mycobacterium intracellulare pneumonia in a child
KRAUSE P, HIGHT D, SCHWARTZ A, MUELLER R, KLEINMAN L, LEOPOLD H, ISEMAN M. Successful management of Mycobacterium intracellulare pneumonia in a child. The Pediatric Infectious Disease Journal 1986, 5: 269-271. PMID: 3952014, DOI: 10.1097/00006454-198603000-00022.Peer-Reviewed Case Reports and Technical Notes